- Report
- May 2026
- 140 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- August 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- March 2026
- 155 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- May 2026
- 550 Pages
Global
From €3695EUR$3,995USD£3,084GBP
- Report
- May 2026
- 250 Pages
Global
From €3695EUR$3,995USD£3,084GBP
- Report
- May 2026
- 300 Pages
Global
From €3695EUR$3,995USD£3,084GBP
- Report
- May 2026
- 450 Pages
Global
From €3695EUR$3,995USD£3,084GBP
- Report
- May 2026
- 500 Pages
Global
From €4620EUR$4,995USD£3,856GBP
- Report
- June 2026
- 593 Pages
Global
From €4158EUR$4,495USD£3,470GBP
- Report
- November 2026
- 685 Pages
Global
From €4158EUR$4,495USD£3,470GBP
- Report
- November 2026
- 465 Pages
Global
From €4158EUR$4,495USD£3,470GBP
- Report
- April 2026
- 424 Pages
Global
From €5395EUR$6,037USD£4,350GBP
- Report
- February 2026
- 320 Pages
Global
From €4578EUR$4,950USD£3,821GBP
- Report
- October 2026
- 77 Pages
Global
From €2081EUR$2,250USD£1,737GBP
- Report
- October 2026
- 455 Pages
Global
From €4439EUR$4,799USD£3,704GBP
- Report
- October 2026
- 217 Pages
Global
From €4439EUR$4,799USD£3,704GBP
- Report
- August 2026
- 325 Pages
Global
From €4439EUR$4,799USD£3,704GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more